Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI
NCT ID: NCT03165396
Last Updated: 2018-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2016-11-10
2018-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome
NCT02766062
The Effect of General Anesthesia with Remimazolam and Propofol on Rhythmic State and Cognitive Function
NCT06775366
Role of Propofol Postconditioning on Oxidative Stress and Cognitive Function
NCT02691416
To Study the Effect of Sevoflurane and Propofol V Sevoflurane and Dexmedetomidine on Postoperative Cognitive Dysfunction
NCT03145714
The Difference in Cerebral Oxygenation Between Propofol and Sevoflurane
NCT01757561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propofol
administrated Target Controlled Infusion （TCI）of propofol （Cp 2.0\~2.5μg/ml ）for maintaining
Propofol
Propofol is the most common clinical anesthetics.
1.2 μg/ml Propofol
administrated Target Controlled Infusion （TCI）of propofol （Cp 1.2 μg/ml ）combined with appropriate sevoflurane for maintaining
Propofol
Propofol is the most common clinical anesthetics.
Sevoflurane
Sevoflurane is the most common clinical anesthetics.
0.6 μg/ml Propofol
administrated Target Controlled Infusion （TCI）of propofol （Cp 0.6 μg/ml ）combined with appropriate sevoflurane for maintaining
Propofol
Propofol is the most common clinical anesthetics.
Sevoflurane
Sevoflurane is the most common clinical anesthetics.
Sevoflurane
administrated 1.3 minimum alveolar concentration（MAC ） sevoflurane for maintaining
Sevoflurane
Sevoflurane is the most common clinical anesthetics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol
Propofol is the most common clinical anesthetics.
Sevoflurane
Sevoflurane is the most common clinical anesthetics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists physical status: II
Exclusion Criteria
* Hypothyroidism
* Alcoholic dementia
50 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Third Central Clinical College of Tianjin Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Third Central Hospital of Tianjin
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
szxlcyj-chen
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.